Found 4 matching trials
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
PHASE2The purpose of this observer blinded study is to provide information on vac...
Location
GSK Investigational Site
MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.
N/AHealthy children who received two doses of GlaxoSmithKline (GSK) Biological...
Location
Multiple Locations
Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
PHASE3The purpose of this study is to assess non-inferiority of two different vac...
Location
GSK Investigational Site
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
PHASE3This Phase 3b study is being conducted for the purpose of registration of t...
Location
GSK Investigational Site